Oxford Vaccine Trial India: Oxford vaccine AZD1222 showed a favourable response in phase I of human trials

Oxford Vaccine Partner, Serum institute plans to begin clinical trials of Oxford COVID Vaccine in India. The Oxford COVID vaccine trials have shown the most promising results. The trials are currently much ahead of other clinical trials happening around the world.

The clinical trials for the Oxford COVID vaccine will begin in India as soon as the required licence is procured. Serum Institute of India, which is the world’s largest vaccine manufacturer, is partnering with the Oxford researchers to develop the vaccine.

The Oxford Vaccine trials have shown that the COVID vaccine could potentially offer double protection against COVID-19.